Jane Street Group, LLC Hepion Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.57 - $1.22 $9,703 - $20,769	17,024 Added 72.69%	40,445 $23,000
Q1 2022 May 17, 2022	SELL	$0.93 - $1.29 $21,834 - $30,286	-23,478 Reduced 50.06%	23,421 $30,000
Q4 2021 Feb 15, 2022	BUY	$1.14 - $1.58 $53,464 - $74,100	46,899 New	46,899 $53,000
Q3 2021 Nov 16, 2021	SELL	$1.39 - $2.1 $25,475 - $38,488	-18,328 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.56 - $2.26 $8,887 - $12,875	5,697 Added 45.1%	18,328 $36,000
Q1 2021 May 18, 2021	BUY	$1.77 - $2.98 $22,356 - $37,640	12,631 New	12,631 $23,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.